Hepatocellular Carcinoma, Peritoneal Carcinoma
Conditions
Keywords
COVID-19, Cancer, Health Care Quality Indicators, hepatocellular carcinoma, peritoneal carcinosis
Brief summary
The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments). Data collection will focus on the analysis of 2 specific pathologies for French patients in the Auvergne-Rhône Alpes Area: peritoneal carcinosis and hepatocellular carcinoma.
Interventions
OTHERCOLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
The following items will be collected * Diagnostic date * Diagnostic stage * Date of surgery * Date of surgery appointment * First antineoplastic treatment date * Last antineoplastic treatment date * Number of treatment cycles recommanded by MDTM
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients hospitalized in France for peritoneal carcinosis or hepatocellular carcinoma between 2017 and 2020.
Exclusion criteria
* Patients who did not allow the reuse of their medical data for research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019) | 24 months | The difference between a set of different activity indicators will be compared between 2020 and the average activities of previous periods (2017-2019) |
Countries
France
Outcome results
None listed